San Francisco, CA
Ouroboros Medicines is a biotechnology company that specializes in immunology and focuses on treating long-term immune-mediated illnesses. The company addresses chronic immune-mediated conditions directly by integrating scientific knowledge, a proven history of progressing cell-depleting treatments through clinical trials, and a strong pipeline.
ouromedicines.comGet the inside track on Ouro Medicines
Save jobs, AI research, premium profiles, and 61K+ ATS listings. $25/mo — 7 days free.
These are collections Ouro Medicines is a part of. Click on the collection name to view similar companies.
Series A
$120,000,000
Series A
$120,000,000
0 out of 5 stars
Based on 0 reviews
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Ouro Medicines.